Middleton & Co’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$758K Hold
3,600
– – 0.08% 107
2026
Q2
$685K Hold
3,600
– – 0.07% 111
2026
Q1
$608K Hold
3,600
– – 0.07% 109
2025
Q4
$608K Hold
3,600
– – 0.06% 104
2025
Q3
$520K Hold
3,600
– – 0.06% 113
2025
Q2
$455K Hold
3,600
– – 0.05% 119
2025
Q1
$460K Hold
3,600
– – 0.05% 115
2024
Q4
$476K Hold
3,600
– – 0.05% 110
2024
Q3
$524K Hold
3,600
– – 0.06% 111
2024
Q2
$494K Hold
3,600
– – 0.06% 109
2024
Q1
$494K Hold
3,600
– – 0.06% 114
2023
Q4
$489K Hold
3,600
– – 0.06% 106
2023
Q3
$440K Hold
3,600
– – 0.06% 106
2023
Q2
$457K Hold
3,600
– – 0.06% 110
2023
Q1
$465K Hold
3,600
– – 0.07% 109
2022
Q4
$473K Hold
3,600
– – 0.07% 111
2022
Q3
$421K Sell
3,600
-225
-6% -$27.9K 0.06% 108
2022
Q2
$450K Hold
3,825
– – 0.06% 115
2022
Q1
$498K Hold
3,825
– – 0.05% 120
2021
Q4
$584K Sell
3,825
-600
-14% -$92.9K 0.06% 120
2021
Q3
$715K Hold
4,425
– – 0.08% 107
2021
Q2
$724K Hold
4,425
– – 0.08% 105
2021
Q1
$666K Buy
+4,425
New +$703K 0.08% 106

Other funds holding IBB

Middleton & Co's IBB Position: Q3 2026 in Review

Middleton & Co held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 3,600 shares worth $758K. The position accounts for 0.08% of the portfolio, ranked #107.

Middleton & Co first reported a position in IBB in Q1 2021 and has held it in 23 quarters since. 434 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Middleton & Co held 3,600 shares of iShares Biotechnology ETF worth $758K as of Q3 2026.
  • Middleton & Co left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.08% of Middleton & Co's portfolio in Q3 2026, its #107 holding.
  • Middleton & Co first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 23 quarters since.
  • 434 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Middleton & Co's 13F filing for Q3 2026, filed 23 Oct 2026.